Expert Answers to Frequently Asked Questions Regarding HCV Elimination in Key Patient Populations

In this downloadable slideset, Frederick L. Altice, MD, Christian Ramers MD, MPH, and Lara Strick, MD, respond to common questions on the elimination of HCV infection in key high-risk communities.
Format: Microsoft PowerPoint (.ppt)
File Size: 630 KB
Released: October 18, 2017

Acknowledgements

Educational grant provided by:
Gilead Sciences

Related Content

CCO downloadable slides from Dr. Tatyana Kushner providing insights on updated guidance for HCV screening and management in women of childbearing age

Tatyana Kushner, MD, MSCE Released: January 8, 2021

CCO module by Dr. Mark Sulkowski on optimal HCV management in PWID, children, liver transplant recipients and patients with renal disease or HIV

Stefan Zeuzem, MD
Program Director
Mark S. Sulkowski, MD
Released: December 28, 2020

CCO commentary from Catherine Chappell, MD, MSc, on the challenges of HCV management in women of childbearing age, including during pregnancy.

person default Catherine Chappell, MD, MSc Released: December 22, 2020

CCO commentary from Tatyana Kushner, MD, MSCE, on the important role of universal HCV testing for pregnant women

Tatyana Kushner, MD, MSCE Released: December 14, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue